Drug Patent Expirations for Apr 7, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. ZYRTEC-D 12 HOUR (cetirizine hydrochloride; pseudoephedrine hydrochloride) J And J Consumer Inc Patent number: 6,489,329 Expiration Date: Apr 8, 2016 TYGACIL (tigecycline) Pf Prism Cv Patent […]


Drug Patent Expirations for Mar 31, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. LONSURF (tipiracil hydrochloride; trifluridine) Taiho Oncology Patent number: 5,744,475 Expiration Date: Mar 28, 2016 EMTRIVA (emtricitabine) Gilead Patent number: 5,814,639 Expiration Date: Mar 29, 2016 COMPLERA […]


Drug Patent Expirations for Mar 24, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. INTUNIV (guanfacine hydrochloride) Shire Patent number: 5,854,290 Expiration Date: Mar 21, 2016 PAXIL (paroxetine hydrochloride) Apotex Technologies Patent number: 5,811,436 Expiration Date: Mar 22, 2016 MUSE […]


Which pharmaceutical companies have the most “New Dosage Form” drugs?

New Dosage Forms are one of the categories for which the FDA grants three years of exclusivity for ‘New Clinical Investigations.’ Alternate categories worth of three years of protection include identifying a New Patient Population, New Product, or New Strength. This chart shows the companies which have received the most New Dosage Form exclusivities in […]


Drug Patent Expirations for Mar 17, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. FLO-PRED (prednisolone acetate) Taro Patent number: 5,881,926 Expiration Date: Mar 16, 2016 DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs. For more information try […]


Which pharma companies have the most ‘New Dosage Form’ exclusivities?

New Dosage Forms are one of the categories for which the FDA grants three years of exclusivity for ‘New Clinical Investigations.’ Alternate categories worth of three years of protection include identifying a New Patient Population, New Product, or New Strength. This chart shows the companies which have received the most New Dosage Form exclusivities in […]


Drug Patent Expirations for Mar 10, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. METVIXIA (methyl aminolevulinate hydrochloride) Galderma Labs Lp Patent number: 6,034,267 Expiration Date: Mar 8, 2016 SUMAVEL DOSEPRO (sumatriptan succinate) Endo Ventures Ltd Patent number: 5,957,886 Expiration […]


Drug Patent Expirations for Mar 3, 2016

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. LUXIQ (betamethasone valerate) Delcor Asset Patent number: 6,126,920 Expiration Date: Mar 1, 2016 FAMVIR (famciclovir) Novartis Patent number: 5,916,893 Expiration Date: Mar 1, 2016 ZELAPAR (selegiline hydrochloride) Valeant […]


Bioentrepreneurship education programmes in the United States

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Bioentrepreneurship education programmes in the United States
Go to paperABSTRACT: In this first paper of a new regular column, Arlen Meyers and Patrick…


Get email updates

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Subscribe!